Nova Eye Medical Limited
ELXMF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5 | $6 | $7 | $8 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $4 | $4 | $2 | $2 |
| Inventory | $3 | $4 | $4 | $4 |
| Other Curr. Assets | $0 | $0 | $1 | $2 |
| Total Curr. Assets | $12 | $15 | $15 | $16 |
| Property Plant & Equip (Net) | $3 | $4 | $2 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $7 | $7 | $13 | $18 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $11 | $10 |
| Other NC Assets | $4 | $4 | -$11 | -$10 |
| Total NC Assets | $14 | $15 | $16 | $21 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $27 | $30 | $30 | $37 |
| Liabilities | – | – | – | – |
| Payables | $2 | $4 | $4 | $2 |
| Short-Term Debt | $1 | $0 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $2 | $1 | $1 |
| Total Curr. Liab. | $5 | $6 | $6 | $4 |
| LT Debt | $2 | $3 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | -$1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $1 |
| Other NC Liab. | $0 | $0 | $0 | $1 |
| Total NC Liab. | $2 | $3 | $1 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $3 | $2 | $2 |
| Total Liabilities | $8 | $9 | $7 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $59 | $53 | $45 | $37 |
| Retained Earnings | -$40 | -$31 | -$22 | -$7 |
| AOCI | -$0 | -$1 | -$0 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $19 | $21 | $23 | $30 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $27 | $30 | $30 | $37 |
| Net Debt | -$2 | -$3 | -$6 | -$6 |